Safety of a new spray ‐type adhesion barrier (AdSpray®) in liver surgery

ConclusionsAdSpray used was not associated with global incidence of major morbidity after liver surgery, although surgeon ’s experience would be needed for adequate use of AdSpray to minimize the risk of postoperative abscess formation.

Source: Journal of Hepato-Biliary-Pancreatic Sciences - June 7, 2020 Category: Gastroenterology Authors: Satoshi Okubo, Junichi Shindoh, Yuta Kobayashi, Masaji Hashimoto Tags: ORIGINAL ARTICLE Source Type: research